SHATTUCK LABS INC. - COMMON STOCK

Shattuck Labs Announces Participation in Upcoming November Conferences

03 ноя 2022 08:30:01 Источник Nasdaq GlobeNewswire

Shattuck Labs to Report Third Quarter 2022 Financial Results on November 8, 2022

01 ноя 2022 16:30:00 Источник Nasdaq GlobeNewswire

Shattuck Labs to Present Updated Preclinical Data on Gamma Delta T Cell Engager (GADLEN) Platform Candidates at the Society for Immunotherapy of Cancer (SITC) Annual Meeting November 8-12

05 окт 2022 16:30:00 Источник Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming September Conferences

01 сен 2022 16:15:00 Источник Nasdaq GlobeNewswire

Shattuck Labs Reports Second Quarter 2022 Financial Results and Recent Business Highlights

11 авг 2022 07:00:02 Источник Nasdaq GlobeNewswire

Shattuck Labs Reports First Quarter 2022 Financial Results and Recent Business Highlights

12 май 2022 07:00:02 Источник Nasdaq GlobeNewswire

Shattuck Labs Presents Preclinical Data at the 2022 American Association for Cancer Research (AACR) Annual Meeting

08 апр 2022 16:55:10 Источник Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming 21st Annual Needham Virtual Healthcare Conference

05 апр 2022 17:00:00 Источник Nasdaq GlobeNewswire

Shattuck Labs Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights

15 мар 2022 07:00:01 Источник Nasdaq GlobeNewswire

Shattuck Labs to Present Two Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting

09 мар 2022 08:21:32 Источник Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming March Conferences

02 мар 2022 08:39:20 Источник Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming 11th Annual SVB Leerink Global Healthcare Conference

09 фев 2022 17:00:00 Источник Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming January Investor Conferences

05 янв 2022 08:30:00 Источник Nasdaq GlobeNewswire

Shattuck Labs to Present at TIGIT Therapies Digital Summit 2021

02 дек 2021 07:17:26 Источник Nasdaq GlobeNewswire

Shattuck Labs Reports Third Quarter 2021 Financial Results and Recent Business Highlights

09 ноя 2021 08:00:04 Источник Nasdaq GlobeNewswire

Shattuck Labs Announces Preliminary Clinical Data from Ongoing Phase 1 Clinical Trials of ARC Fusion Proteins SL-172154 and SL-279252

09 ноя 2021 08:00:03 Источник Nasdaq GlobeNewswire

Shattuck Labs to Host Conference Call and Webcast Highlighting Data Presented at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

04 ноя 2021 07:00:01 Источник Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming November Investor Conferences

03 ноя 2021 17:19:24 Источник Nasdaq GlobeNewswire

Shattuck Labs Announces Changes to its Board of Directors

28 окт 2021 16:30:00 Источник Nasdaq GlobeNewswire

Shattuck Labs to Present Clinical Data on SL-172154 and SL-279252 and Preclinical Data on SL-9258 at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

01 окт 2021 09:56:18 Источник Nasdaq GlobeNewswire